3
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

3
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Iohexol Injection Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-8R10405
Home | Market Reports | Health| Pharmacy
Global Iohexol Injection Market Insights Forecast to 2028
BUY CHAPTERS

Global Iohexol Injection Market Research Report 2025

Code: QYRE-Auto-8R10405
Report
July 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Iohexol Injection Market Size

The global market for Iohexol Injection was valued at US$ 1344 million in the year 2024 and is projected to reach a revised size of US$ 1897 million by 2031, growing at a CAGR of 5.1% during the forecast period.

Iohexol Injection Market

Iohexol Injection Market

Iohexol injection is a non-ionic, water-soluble contrast agent used in diagnostic imaging procedures such as computed tomography (CT) scans and angiography to enhance the visibility of blood vessels, tissues, and organs by highlighting their structures and abnormalities for accurate diagnosis and treatment planning.
Market Drivers:
Diagnostic Precision: Iohexol injection aids in improving diagnostic accuracy by providing enhanced contrast in imaging studies, enabling healthcare professionals to visualize internal body structures with greater clarity and detail for accurate interpretation.
Safety Profile: As a non-ionic contrast agent, iohexol is associated with lower risk of adverse reactions compared to ionic contrast media, making it a preferred choice for patients with a history of sensitivity to contrast agents and reducing the incidence of allergic responses during imaging procedures.
Renal Safety: Iohexol has a lower risk of causing contrast-induced nephropathy (CIN) compared to some other contrast agents, making it a safer option for patients with compromised renal function or those at higher risk of kidney injury following contrast-enhanced imaging studies.
Technological Advancements: Ongoing research and development efforts focus on enhancing the formulation of iohexol injection, improving patient tolerability, reducing osmolality, and optimizing imaging protocols to deliver high-quality diagnostic images while ensuring patient safety.
Clinical Applications: The versatility of iohexol injection in various imaging modalities, including CT scans, angiography, and other radiological procedures, drives its widespread use in diagnostic imaging across medical specialties such as radiology, interventional cardiology, and vascular surgery.
Market Challenges:
Competitive Landscape: The contrast media market is competitive, with multiple manufacturers offering a range of contrast agents, including iohexol, leading to pricing pressures, market saturation, and challenges in differentiating products based on efficacy, safety, and cost-effectiveness.
Regulatory Compliance: Compliance with stringent regulatory requirements, quality standards, and safety guidelines for contrast media production, labeling, and distribution poses challenges for manufacturers in ensuring product quality, consistency, and regulatory approval for market authorization.
Cost Constraints: The cost of contrast media, imaging procedures, and healthcare services can be a barrier for some healthcare facilities, patients, and healthcare systems, impacting the accessibility and affordability of contrast-enhanced imaging studies utilizing iohexol injection.
Patient Factors: Variability in patient factors such as allergies, renal function, comorbidities, and medication history can influence the choice of contrast agents, dosing considerations, and risk assessment for iohexol injection, requiring individualized patient care and monitoring.
Adverse Events Management: Despite its favorable safety profile, iohexol injection can still lead to adverse reactions such as hypersensitivity reactions, nephrotoxicity, and rare but serious side effects, necessitating prompt recognition, management, and mitigation of adverse events during and after imaging procedures.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Iohexol Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iohexol Injection.
The Iohexol Injection market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Iohexol Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iohexol Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Iohexol Injection Market Report

Report Metric Details
Report Name Iohexol Injection Market
Accounted market size in year US$ 1344 million
Forecasted market size in 2031 US$ 1897 million
CAGR 5.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 350mg I/ml
  • 240mg I/ml
  • 300mg I/ml
  • Others
Segment by Application
  • Hospitals
  • Clinics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GE Healthcare, YRPG, BeiLu Pharma, Imax
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Iohexol Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Iohexol Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Iohexol Injection Market growing?

Ans: The Iohexol Injection Market witnessing a CAGR of 5.1% during the forecast period 2025-2031.

What is the Iohexol Injection Market size in 2031?

Ans: The Iohexol Injection Market size in 2031 will be US$ 1897 million.

Who are the main players in the Iohexol Injection Market report?

Ans: The main players in the Iohexol Injection Market are GE Healthcare, YRPG, BeiLu Pharma, Imax

What are the Application segmentation covered in the Iohexol Injection Market report?

Ans: The Applications covered in the Iohexol Injection Market report are Hospitals, Clinics

What are the Type segmentation covered in the Iohexol Injection Market report?

Ans: The Types covered in the Iohexol Injection Market report are 350mg I/ml, 240mg I/ml, 300mg I/ml, Others

Recommended Reports

Contrast Agents Market

Imaging Devices & Systems

Contrast Injectors & APIs

1 Iohexol Injection Market Overview
1.1 Product Definition
1.2 Iohexol Injection by Type
1.2.1 Global Iohexol Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 350mg I/ml
1.2.3 240mg I/ml
1.2.4 300mg I/ml
1.2.5 Others
1.3 Iohexol Injection by Application
1.3.1 Global Iohexol Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Iohexol Injection Market Size Estimates and Forecasts
1.4.1 Global Iohexol Injection Revenue 2020-2031
1.4.2 Global Iohexol Injection Sales 2020-2031
1.4.3 Global Iohexol Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Iohexol Injection Market Competition by Manufacturers
2.1 Global Iohexol Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Iohexol Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Iohexol Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Iohexol Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Iohexol Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Iohexol Injection, Product Type & Application
2.7 Global Key Manufacturers of Iohexol Injection, Date of Enter into This Industry
2.8 Global Iohexol Injection Market Competitive Situation and Trends
2.8.1 Global Iohexol Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Iohexol Injection Players Market Share by Revenue
2.8.3 Global Iohexol Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Iohexol Injection Market Scenario by Region
3.1 Global Iohexol Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Iohexol Injection Sales by Region: 2020-2031
3.2.1 Global Iohexol Injection Sales by Region: 2020-2025
3.2.2 Global Iohexol Injection Sales by Region: 2026-2031
3.3 Global Iohexol Injection Revenue by Region: 2020-2031
3.3.1 Global Iohexol Injection Revenue by Region: 2020-2025
3.3.2 Global Iohexol Injection Revenue by Region: 2026-2031
3.4 North America Iohexol Injection Market Facts & Figures by Country
3.4.1 North America Iohexol Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Iohexol Injection Sales by Country (2020-2031)
3.4.3 North America Iohexol Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Iohexol Injection Market Facts & Figures by Country
3.5.1 Europe Iohexol Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Iohexol Injection Sales by Country (2020-2031)
3.5.3 Europe Iohexol Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Iohexol Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Iohexol Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Iohexol Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Iohexol Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Iohexol Injection Market Facts & Figures by Country
3.7.1 Latin America Iohexol Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Iohexol Injection Sales by Country (2020-2031)
3.7.3 Latin America Iohexol Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Iohexol Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Iohexol Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Iohexol Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Iohexol Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Iohexol Injection Sales by Type (2020-2031)
4.1.1 Global Iohexol Injection Sales by Type (2020-2025)
4.1.2 Global Iohexol Injection Sales by Type (2026-2031)
4.1.3 Global Iohexol Injection Sales Market Share by Type (2020-2031)
4.2 Global Iohexol Injection Revenue by Type (2020-2031)
4.2.1 Global Iohexol Injection Revenue by Type (2020-2025)
4.2.2 Global Iohexol Injection Revenue by Type (2026-2031)
4.2.3 Global Iohexol Injection Revenue Market Share by Type (2020-2031)
4.3 Global Iohexol Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Iohexol Injection Sales by Application (2020-2031)
5.1.1 Global Iohexol Injection Sales by Application (2020-2025)
5.1.2 Global Iohexol Injection Sales by Application (2026-2031)
5.1.3 Global Iohexol Injection Sales Market Share by Application (2020-2031)
5.2 Global Iohexol Injection Revenue by Application (2020-2031)
5.2.1 Global Iohexol Injection Revenue by Application (2020-2025)
5.2.2 Global Iohexol Injection Revenue by Application (2026-2031)
5.2.3 Global Iohexol Injection Revenue Market Share by Application (2020-2031)
5.3 Global Iohexol Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Company Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Iohexol Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GE Healthcare Iohexol Injection Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 YRPG
6.2.1 YRPG Company Information
6.2.2 YRPG Description and Business Overview
6.2.3 YRPG Iohexol Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 YRPG Iohexol Injection Product Portfolio
6.2.5 YRPG Recent Developments/Updates
6.3 BeiLu Pharma
6.3.1 BeiLu Pharma Company Information
6.3.2 BeiLu Pharma Description and Business Overview
6.3.3 BeiLu Pharma Iohexol Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BeiLu Pharma Iohexol Injection Product Portfolio
6.3.5 BeiLu Pharma Recent Developments/Updates
6.4 Imax
6.4.1 Imax Company Information
6.4.2 Imax Description and Business Overview
6.4.3 Imax Iohexol Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Imax Iohexol Injection Product Portfolio
6.4.5 Imax Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Iohexol Injection Industry Chain Analysis
7.2 Iohexol Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Iohexol Injection Production Mode & Process Analysis
7.4 Iohexol Injection Sales and Marketing
7.4.1 Iohexol Injection Sales Channels
7.4.2 Iohexol Injection Distributors
7.5 Iohexol Injection Customer Analysis
8 Iohexol Injection Market Dynamics
8.1 Iohexol Injection Industry Trends
8.2 Iohexol Injection Market Drivers
8.3 Iohexol Injection Market Challenges
8.4 Iohexol Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Iohexol Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Iohexol Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Iohexol Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Iohexol Injection Sales (K L) of Key Manufacturers (2020-2025)
 Table 5. Global Iohexol Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Iohexol Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Iohexol Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Iohexol Injection Average Price (US$/L) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Iohexol Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Iohexol Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Iohexol Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Iohexol Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Iohexol Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iohexol Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Iohexol Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Iohexol Injection Sales by Region (2020-2025) & (K L)
 Table 18. Global Iohexol Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Iohexol Injection Sales by Region (2026-2031) & (K L)
 Table 20. Global Iohexol Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Iohexol Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Iohexol Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Iohexol Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Iohexol Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Iohexol Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Iohexol Injection Sales by Country (2020-2025) & (K L)
 Table 27. North America Iohexol Injection Sales by Country (2026-2031) & (K L)
 Table 28. North America Iohexol Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Iohexol Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Iohexol Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Iohexol Injection Sales by Country (2020-2025) & (K L)
 Table 32. Europe Iohexol Injection Sales by Country (2026-2031) & (K L)
 Table 33. Europe Iohexol Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Iohexol Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Iohexol Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Iohexol Injection Sales by Region (2020-2025) & (K L)
 Table 37. Asia Pacific Iohexol Injection Sales by Region (2026-2031) & (K L)
 Table 38. Asia Pacific Iohexol Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Iohexol Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Iohexol Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Iohexol Injection Sales by Country (2020-2025) & (K L)
 Table 42. Latin America Iohexol Injection Sales by Country (2026-2031) & (K L)
 Table 43. Latin America Iohexol Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Iohexol Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Iohexol Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Iohexol Injection Sales by Country (2020-2025) & (K L)
 Table 47. Middle East and Africa Iohexol Injection Sales by Country (2026-2031) & (K L)
 Table 48. Middle East and Africa Iohexol Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Iohexol Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Iohexol Injection Sales (K L) by Type (2020-2025)
 Table 51. Global Iohexol Injection Sales (K L) by Type (2026-2031)
 Table 52. Global Iohexol Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Iohexol Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Iohexol Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Iohexol Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Iohexol Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Iohexol Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Iohexol Injection Price (US$/L) by Type (2020-2025)
 Table 59. Global Iohexol Injection Price (US$/L) by Type (2026-2031)
 Table 60. Global Iohexol Injection Sales (K L) by Application (2020-2025)
 Table 61. Global Iohexol Injection Sales (K L) by Application (2026-2031)
 Table 62. Global Iohexol Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Iohexol Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Iohexol Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Iohexol Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Iohexol Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Iohexol Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Iohexol Injection Price (US$/L) by Application (2020-2025)
 Table 69. Global Iohexol Injection Price (US$/L) by Application (2026-2031)
 Table 70. GE Healthcare Company Information
 Table 71. GE Healthcare Description and Business Overview
 Table 72. GE Healthcare Iohexol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 73. GE Healthcare Iohexol Injection Product
 Table 74. GE Healthcare Recent Developments/Updates
 Table 75. YRPG Company Information
 Table 76. YRPG Description and Business Overview
 Table 77. YRPG Iohexol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 78. YRPG Iohexol Injection Product
 Table 79. YRPG Recent Developments/Updates
 Table 80. BeiLu Pharma Company Information
 Table 81. BeiLu Pharma Description and Business Overview
 Table 82. BeiLu Pharma Iohexol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 83. BeiLu Pharma Iohexol Injection Product
 Table 84. BeiLu Pharma Recent Developments/Updates
 Table 85. Imax Company Information
 Table 86. Imax Description and Business Overview
 Table 87. Imax Iohexol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 88. Imax Iohexol Injection Product
 Table 89. Imax Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Iohexol Injection Distributors List
 Table 93. Iohexol Injection Customers List
 Table 94. Iohexol Injection Market Trends
 Table 95. Iohexol Injection Market Drivers
 Table 96. Iohexol Injection Market Challenges
 Table 97. Iohexol Injection Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Iohexol Injection
 Figure 2. Global Iohexol Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Iohexol Injection Market Share by Type: 2024 & 2031
 Figure 4. 350mg I/ml Product Picture
 Figure 5. 240mg I/ml Product Picture
 Figure 6. 300mg I/ml Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Iohexol Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Iohexol Injection Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Clinics
 Figure 12. Global Iohexol Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Iohexol Injection Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Iohexol Injection Sales (2020-2031) & (K L)
 Figure 15. Global Iohexol Injection Average Price (US$/L) & (2020-2031)
 Figure 16. Iohexol Injection Report Years Considered
 Figure 17. Iohexol Injection Sales Share by Manufacturers in 2024
 Figure 18. Global Iohexol Injection Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Iohexol Injection Players: Market Share by Revenue in Iohexol Injection in 2024
 Figure 20. Iohexol Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Iohexol Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Iohexol Injection Sales Market Share by Country (2020-2031)
 Figure 23. North America Iohexol Injection Revenue Market Share by Country (2020-2031)
 Figure 24. United States Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Iohexol Injection Sales Market Share by Country (2020-2031)
 Figure 27. Europe Iohexol Injection Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Iohexol Injection Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Iohexol Injection Revenue Market Share by Region (2020-2031)
 Figure 35. China Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Iohexol Injection Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Iohexol Injection Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Iohexol Injection Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Iohexol Injection Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Iohexol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Iohexol Injection by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Iohexol Injection by Type (2020-2031)
 Figure 56. Global Iohexol Injection Price (US$/L) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Iohexol Injection by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Iohexol Injection by Application (2020-2031)
 Figure 59. Global Iohexol Injection Price (US$/L) by Application (2020-2031)
 Figure 60. Iohexol Injection Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart